AbbVie (ABBV) Treasury Shares (2013 - 2026)

AbbVie (ABBV) has 14 years of Treasury Shares data on file, last reported at $10.6 billion in Q1 2026.

• Quarterly Treasury Shares rose 16.13% year-over-year to $10.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 billion (up 16.13% YoY) and the FY2025 annual result came in at $9.1 billion, up 11.52% from the prior year.
• Treasury Shares improved to $10.6 billion in Q1 2026 per ABBV's latest filing, from $9.1 billion in the prior quarter.
• Across five years, Treasury Shares topped out at $77.1 million in Q1 2026 and bottomed at $5.0 million in Q1 2025.
• The 5-year median for Treasury Shares is $10.0 million (2022), against an average of $21.9 million.
• The widest annual swing landed in 2022, when Treasury Shares jumped 51.99%; it then gained 11.52% in 2025.
• Tracing ABBV's Treasury Shares over 5 years: stood at $4.6 billion in 2022, then soared by 42.21% to $6.5 billion in 2023, then rose by 25.53% to $8.2 billion in 2024, then grew by 11.52% to $9.1 billion in 2025, then rose by 16.02% to $10.6 billion in 2026.
• Per Business Quant, the three latest ABBV Treasury Shares figures stand at $10.6 billion (Q1 2026), $9.1 billion (Q4 2025), and $9.1 billion (Q3 2025).

Peer Comparison